Global High-flow Nasal Cannula Market to Exhibit Robust 12% Growth through 2025 The number of respiratory diseases have burgeoned in recent years. Diseases such as acute respiratory disease syndrome, chronic obstructive pulmonary disease (COPD) and bronchiectasis have become more prevalent among patients. Deteriorating air quality, addiction to smoking and rising pollution are some major factors. Based on the abovementioned trends, the global high-flow nasal cannula market is foreseen to expand credibly in the future. The global high-flow nasal cannula market is anticipated to register a staggering CAGR of 11.8% during the forecast period (2020-2025). The market is anticipated to double, surpassing a value of US$ 9.0 Bn by the end of 2025. Technological advancements by key players and ongoing clinical trials for new technology are also set to leverage the market. For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4777 Key Takeaways of Global High-flow Nasal Cannula Market Study:
Active Humidifiers are anticipated to account for a major chunk of the global high-flow nasal cannula market (>1/4th). Growing focus on the efficiency of humidified oxygen supply in high-flow nasal cannula therapy shall drive innovations in the components segment. This is anticipated to leverage the market. By application, active respiratory failure shall leverage the high-flow nasal cannula market. The specific advantages offered by the high-flow nasal cannula market coupled with growing acceptance among patients are key growth drivers. The segment is poised to hold three-tenth of the high-flow nasal cannula market. The Sleep Apnea segment is the second-most lucrative in the global high-flow nasal cannula market. The segment shall grow impressively at a CAGR of 13.5% during the forecast period. By region, North America shall dominate the global high-flow nasal cannula market. Adoption of Non-invasive ventilation (NIV) and continuous positive airway pressure (CPAP) procedures is anticipated to augment the high-flow nasal cannula market. The region shall capture more than two-fifth of the overall market. Asia-Pacific shows lucrative growth opportunity. It is anticipated to expand at a CAGR of 13.2%, capturing more than one-fifth of the market. Rising population and the consequent prevalence of respiratory disorders is projected to boost the Asia-Pacific high-flow nasal cannula market.
For critical insights on this market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4777 Technological Enhancement to Remain Key Premise for Market Expansion: